Over 350 million people worldwide suffer from depression, a third of whom are medication-resistant. Seizure therapy remains the most effective treatment in depression, even when many treatments fail. The utility of seizure therapy is limited due to its cognitive side effects and stigma. The biological targets of seizure therapy remain unknown, hindering design of new treatments with comparable efficacy. Seizures impact the brains temporal dynamicity observed through electroencephalography. This dynamicity reflects richness of information processing across distributed brain networks subserving affective and cognitive processes. We investigated the hypothesis that seizure therapy impacts mood (depressive symptoms) and cognition by modulating brain temporal dynamicity. We obtained resting-state electroencephalography from 34 patients (age = 46.0 AE 14.0, 21 females) receiving two types of seizure treatments-electroconvulsive therapy or magnetic seizure therapy. We used multi-scale entropy to quantify the complexity of the brain's temporal dynamics before and after seizure therapy. We discovered that reduction of complexity in fine timescales underlined successful therapeutic response to both seizure treatments. Greater reduction in complexity of fine timescales in parieto-occipital and central brain regions was significantly linked with greater improvement in depressive symptoms. Greater increase in complexity of coarse timescales was associated with greater decline in cognition including the autobiographical memory. These findings were region and timescale specific. That is, change in complexity in occipital regions (e.g. O2 electrode or right occipital pole) at fine timescales was only associated with change in depressive symptoms, and not change in cognition, and change in complexity in parieto-central regions (e.g. Pz electrode or intra and transparietal sulcus) at coarser timescale was only associated with change in cognition, and not depressive symptoms. Finally, region and timescale specific changes in complexity classified both antidepressant and cognitive response to seizure therapy with good (80%) and excellent (95%) accuracy, respectively. In this study, we discovered a novel biological target of seizure therapy: complexity of the brain resting state dynamics. Region and timescale dependent changes in complexity of the brain resting state dynamics is a novel mechanistic marker of response to seizure therapy that explains both the antidepressant response and cognitive changes associated with this treatment. This marker has tremendous potential to guide design of the new generation of antidepressant treatments.
Introduction
Major depression is a leading cause of disability affecting over 350 million people globally (Murray and Lopez, 1996) . Over a third of these patients fail to respond to medications. Dating back to the 1700s, the induction of seizures has been used to treat severe psychiatric conditions such as depression. Introduced in the 1930s, seizure therapy administered through electroconvulsive therapy (ECT) still remains the most effective treatment for depression (The UK ECT Review Group, 2003) even when many other antidepressant treatments have failed. However, the cognitive side effects of ECT (Lisanby et al., 2000; McClintock et al., 2014) limit its widespread use. Magnetic seizure therapy (MST) is an emerging antidepressant treatment that involves the induction of seizure through the administration of transcranial magnetic stimulation (TMS) (Moscrip et al., 2006; Hoy and Fitzgerald, 2010; McClintock et al., 2013) . This approach to seizure induction causes less memory impairment than ECT (McClintock et al., 2013) and early treatment studies report efficacy in depression (Kayser et al., 2015) . Despite decades of research, the biological targets of seizure therapy for depression remain unclear. This has hindered the progress in development of new antidepressant interventions that have comparable efficacy to ECT without the cognitive side effects. Here, we propose a novel approach in examining the biological target of seizure therapy by assessing the impact of seizure on the temporal fluctuations (i.e. dynamics) of brain signals.
Seizure is a biological phenomenon that significantly impacts brain dynamicity visualized through EEG. It is increasingly evident that temporal fluctuations and variability observed in biological systems such as brain signals have a fundamental role in shaping the brain's capacity for information processing (Tononi et al., 1994; Tononi and Edelman, 1998; Sporns et al., 2000; Costa et al., 2005) . This temporal fluctuation, occasionally referred to as biological 'noise', is distinct from random noise and structurally rich (Costa et al., 2005) exhibiting varying degrees of recurring patterns (Costa et al., 2005) . The less recurring temporal patterns, the more complex and unpredictable the signal is. In the brain, the complexity of signals at fine (smaller time increment) and coarse (larger time increments) timescales is proposed to arise from transient increases and decreases in correlated activity among local and distributed brain regions, subserving integration and segregation of information at different spatiotemporal scales (Sporns et al., 2000; McIntosh et al., 2014) . While the majority of existing experiments have quantified the strength of functional coupling between brain regions and its disturbance in disorders of mood and consciousness (Fox et al., 2012; Sale et al., 2015) , emerging evidence points to the abnormalities in the temporal complexity of brain signals in disorders of affect and cognition (McIntosh et al., 2014) .
We hypothesized that seizures impact both mood and cognition by modifying the temporal complexity of brain signals in a timescale-dependent manner. We obtained resting state EEG from two independent cohorts of patients undergoing either MST (n = 15) or ECT (n = 19). Depressive symptoms were rated through the Hamilton Rating Scale for Depression (HAMD). General cognition and autobiographical memory were obtained through the Montreal Cognitive Assessment Scale (MoCA) and Autobiographical Memory Interview (AMI) ( Table 1 ).
Material and methods

Patients
A total of 34 subjects (age = 46.0 AE 14.0, 21 females) diagnosed with treatment-resistant major depressive disorder participated in either of two parallel open-label seizure therapy research protocols at the Centre for Addiction and Mental Health (19 ECT and 15 MST). The demographic and clinical characteristics are presented in Table 1 .
Seizure therapy
ECT was administered with a spECTrum 5000Q Õ device (MECTA Corporation) according to standards of practice . Sixteen patients received right unilateral ultra-brief (RUL-UB) pulse width ECT, one received bitemporal brief pulse width ECT, and two started on RUL-UB and were switched to bitemporal due to lack of efficacy (Table 1) . Treatment sessions occurred twice or three times per week. Seizure threshold titration was used to determine stimulus intensity: RUL-UB was delivered at 6 Â threshold with a pulse width of 0.3-0.37 ms and bitemporal was delivered at 1.5Â threshold with a pulse width of 1.0 ms. ECT treatments were continued until depressive symptoms were in remission or improvement had plateaued (Table 1) . Methohexital was administered for sedation and succinylcholine as neuromuscular blocker. In general, the target dosage was 0.75 mg/kg of methohexital and 0.5 mg/kg of succinylcholine. MST was administered with MagPro Õ MST using a Twin Coil (MagVenture). The centre of each circular coil was placed over F3 and F4, respectively, using the EEG international 10-20 system. This induces the highest electric field strength between the two coils roughly corresponding to Fz (Deng et al., 2013) . The orientation of the magnetic fields was posterior-anterior. Subjects underwent a dose titration procedure to establish convulsive stimulation threshold. At 100 Hz and 50 Hz an initial train of 200 pulses was used followed by increments of 200 pulses with a maximum train of 1000 pulses. At 25 Hz, an initial train of 100 pulses was used with increments of 100 pulses up to a maximum of 500 pulses. Twelve subjects received 100 Hz, two subjects received 50 Hz and one subject received 25 Hz (Table 1 ). All stimulations occurred at the maximum stimulator output of 100%. Threshold seizure was defined as a generalized tonic-clonic activity 520 s of visual motor activity or 525 s of EEG seizure activity. Subsequent treatments occurred three times per week, and were initially delivered with a train 400 pulses longer in the 100 Hz and 50 Hz group and 200 pulses longer in the 25 Hz group. In subjects that had not achieved a 50% reduction in HAMD after three treatments, the dose was increased by 100 pulses (25 Hz), or 200 pulses (50 Hz, 100 Hz) up to a maximum of 500 or 1000 pulses, respectively. A maximum of 24 sessions were allowed in the acute course. Methohexital (n = 9), methohexital with remifentanil (n = 5), and ketamine (n = 1) were administered for sedation and succinylcholine was used as the neuromuscular blocker.
EEG
Ten minutes of resting state eyes closed EEG data were recorded within 1 week prior to the start and within 48 h after the completion of a course of seizure therapy in both ECT and MST protocols. Subjects were instructed to sit in an armchair with eyes closed. EEG recording was through a 64-channel NeuroScan EEG system. The reference electrode was behind the CZ electrode, and ground was behind FZ. The sampling rate was 10 kHz. The online filter setting was 0.05 to 1 kHz. The skin/electrode impedance was kept below 5 k.
Mood
Changes in depressive symptoms were assessed by HAMD within 1 week prior to the start and within 48 h after the completion of a course of seizure therapy in both ECT and MST protocols. Response to treatment was defined as 50% change in HAMD from baseline.
Cognition
Nineteen patients (six ECT and 13 MST) completed the MoCA within 48 h prior to and within a week after a course of seizure therapy in both protocols. In addition, the autobiographical memory interview short form (AMI-SF) was completed in 12 MST patients before and after a course of seizure therapy.
EEG preprocessing
Data were imported into MATLAB (The MathWorks. Inc. Natick, MA, USA) for preprocessing. The open source signal processing functions in EEGLAB toolbox version 12.0 (Delorme and Makeig, 2004) were used for data import and preprocessing. The EEG signals were epoched into segments of 2-s duration and downsampled to 1 kHz. A notch filter (band-stop: 55-65 Hz) was used to remove the 60 Hz noise. EEG signals were bandpass filtered 1-50 Hz to further minimize contamination by high frequency artefact. The infinite impulse response (IIR) Butterworth filter of second order and forward and backward filtering were applied to maintain a zero phase shift. All epochs were manually reviewed and trials and channels containing eye movements, muscle or any other non-physiological artefact were discarded. The data were average rereferenced. 
Power
The EEGLAB function spectopo was used to obtain the power spectrum for each electrode. The relative power was obtained for 1 to 50 Hz frequencies. Relative power was calculated as the ratio in the power of each frequency relative to the sum of power across all frequencies.
Multi-scale entropy
Multi-scale entropy (MSE) was examined across all electrodes using two steps (Costa et al., 2005) 
where represents the scale factor (i.e. timescale) and j 1 j 
where C(m) is the total number of pairs of m consecutive similar data points, C(m + 1) is the total number of pairs of m + 1 consecutive similar data points in the multiple coarse-grained time series. SampleEn quantifies the variability of time series by estimating the predictability of amplitude patterns across a time series. In our experiments, two consecutive data points were used for data matching (i.e. m = 2) and data points were considered to match if their absolute amplitude difference was 515% (i.e. r = 0. 15) of standard deviation of time series. MSE was calculated for a 30-s continuous epoch.
EEG source localization
EEG source localization was performed using an opensource application, Brainstorm (Tadel et al., 2011) . First, the electrode locations of our 68-channel Neuroscan Quik Cap EEG electrode sites were co-registered to the ICBM152 MRI template in Brainstorm. The forward solution was then calculated using the OpenMEEG BEM head model (Gramfort et al., 2010) and the inverse solution was derived using sLORETA (Pascual-Marqui, 2002) , with the solution space constrained to the cortex surface. To localize the dynamics of neural activity, we used the Destrieux Atlas, which provides 148 regions of interest in the MNI co-ordinate space (Destrieux et al., 2010) . After the EEG data were mapped to the 148 regions of interest, MSE and power spectrum measures were calculated for all subjects at these sources.
Statistics
In addition to two intervention groups of ECT and MST, subjects were grouped into two groups of antidepressant responders and non-responders: subjects were grouped as responders if there was a 50% or higher change in HAMD relative to baseline, and non-responders otherwise. Analysis of variance was used to (i) examine the effect of seizure therapy on MSE (1-70 timescales) and relative power (1-50 Hz frequencies) for the main effect of Seizure Therapy Intervention (ECT, MST) and Time (Pre, Post); as well as (ii) Antidepressant Response (Responder, Non-Responder) and Time (Pre, Post) across 60 electrodes in sensor space and 148 regions of interest in source space. Bootstrapping was used to correct for multiple comparisons in the analysis of variance. For the post hoc t-test comparisons, clusterbased non-parametric permutation test (Maris and Oostenveld, 2007) was used to correct for the multiple comparisons in this multi-dimensional dataset [60 channels (or 148 regions of interest) Â 50 frequencies, 60 channels (or 148 regions of interest) Â 70 scales] by assigning significance statistics to the probability of size of clusters formed by pooling adjacent pixels with original test statistics P 5 0.05. The significance of original clusters was defined against probably distribution of clusters obtained through 1000 permutations of the shuffled data labels. Identical parameters were used across the cluster-based permutations: threshold statistics of P 5 0.05, identical neighbourhood, 1000 permutation using Monte Carlo approach with cluster test statistics computed as the maximum of the cluster-level summed values. Analysis of variance, and post hoc paired t-test and independent sample t-test analyses were used to calculate the original test statistics. Spearman correlation coefficient was used to examine the association between change in complexity and symptom severity or cognitive score. Similarly, cluster-based nonparametric permutation test was applied to the behavioural scores to correct for the multiple comparisons in the correlation analyses.
In addition to correlation analysis, it was examined if change in complexity classified patients based on antidepressant and cognitive response. Subjects were grouped to have had cognitive decline if the per cent change in MoCA was negative. For AMI-SF, median performance was used to divide the patients into two groups. The level of prediction was quantified by the receiver operating characteristic (ROC) curve, plotting the sensitivity and specificity of the predictor (change in complexity) across all possible threshold values. To determine the significance of the prediction, the area under the curve (AUC), standard error of the AUC and confidence intervals were quantified for each electrode and source.
Throughout the paper, except otherwise noted, reported statistics are corrected P-values, and descriptive values indicate mean and standard deviation unless otherwise stated. Per cent change (i.e. %Á) in outcome variables is calculated as: [(post treatment score À baseline score)/baseline score] Â 100, except for HAMD which is calculated as [(baseline score À post treatment)/baseline score] Â 100.
Results
The impact of seizure on neural oscillations Post hoc analyses replicated the findings of prior studies that ECT induces an increase in relative power of slow cortical oscillations . This effect was spatially global and present regardless of the ECT therapeutic outcome. It was significant for frequencies 58 Hz in responders ( Supplementary Fig. 1A ) and was between 2-7 Hz in non-responders ( Supplementary  Fig. 1B ). However, the slowing of oscillations was not significant in MST (Supplementary Fig. 1C and D) . Consistently, we replicated the previous finding that the spatially global increase of slow oscillations (e.g. 1 Hz) is associated with decline in general cognition ( Supplementary Fig. 3A ). We found no association between change in slow oscillations and change in depressive symptoms (Supplementary Fig. 2A ).
We discovered that common to ECT and MST responders, there was a global reduction in relative power of oscillations above 18 Hz ( Supplementary Fig. 1A and C). ECT non-responders also had a global decrease in oscillations between 10 to 35 Hz ( Supplementary Fig. 1B) . No changes were observed in MST non-responders (Supplementary Fig. 1D ). Comparing ECT with MST intervention group, we identified that ECT treatment led to higher increases in slow oscillations and higher decreases in high frequency oscillations ( Supplementary Fig. 4A ). This finding was also spatially global. Furthermore, comparing antidepressant responders with non-responders revealed that responders exhibited higher reduction in the power of 22 Hz oscillations and also higher frequency oscillations ( Supplementary Fig. 4B ). This finding was spatially global at $22 Hz, but more local in higher frequencies (30-50Hz). Specifically in 30-50 Hz, the reduction in power is observed in regions such as the inferior frontal sulcus, left orbital part of the frontal inferior gyrus, bilateral preoccipital notch, orbital gyri, lateral orbital sulcus, lateral occi-temporal sulcus, medial orbital sulcus, bilateral parieto-occipital sulcus, or bilateral superior parietal lobule.
The results of correlation analysis revealed that the reduction in high frequency oscillations (gamma, e.g. 45 Hz) was correlated with improvement in depressive symptoms (Supplementary Fig. 2A ). This effect was localized to fronto-central (e.g. AF4, F1, FZ, F2, F4, FC2) and parieto-occipital (e.g. P7, P5, PO7, PO5, PO4, PO6, PO8, O1, OZ) brain regions in sensor space. In source space, there were significant negative clusters in brain areas including the orbital sulci and gyri, bilateral posteriordorsal part of the cingulate gyrus (dPCC), ventral PCC (vPCC), precuneus, parieto-occipital sulcus, occipital pole, inferior temporal gyrus, and lateral occi-temporal sulcus in frequencies higher than 30 Hz ( Supplementary Fig. 5A ).
Finally, a spatially widespread decrease in low frequency oscillation (59 Hz) was correlated with a change in cognition ( Supplementary Fig. 3A ). Source analysis also revealed that this effect was spatially global. Finally, reduction in high frequency oscillations (e.g. 440 Hz) in parieto-central regions (e.g. C1, C3, CZ, CP3, P1, PZ, P2, P4, POZ) was correlated with change in cognition. In source space, this effect was identified primarily in brain regions including the central sulcus, angular gyrus, and subparietal sulcus (Supplementary Fig. 5B ).
The impact of seizure on temporal complexity
We then used MSE (Costa et al., 2005) to quantify the change in complexity of dynamics across multiple timescales. In sensor space, there was a significant (P 5 0.05) main effect of Intervention [df = 72, mean F = 10.5 (4.7 to 27.2)], Time [df = 72, mean F = 6.7 (4.6 to 14.4)] and Intervention Â Time interaction effect [df = 72, mean F = 7.2 (4.5 to 18.6)] across multiple timescales and electrodes. There was also significant main effect of Antidepressant Response [mean F = 5.1 (4.5 to 6. Post hoc analysis revealed that change in temporal complexity was only significantly modified in responders of both seizure therapies. Common to ECT and MST responders, there was a decrease in timescales finer than 20 factors ( Fig. 1A and C) . ECT responders showed a significant (cluster P = 0.003) global decrease in timescales 530 and a significant (cluster P = 0.002) global increase in coarser timescales (spatially global changes are seen in timescales 4 50). Source-space analysis (Fig. 5B) confirmed the spatially global extent of this finding. By contrast, in MST responders, a widespread reduction in timescales 520 was observed (cluster P = 0.033). In MST responders, the reduction of MSE in fine timescales (e.g. scale factor 4) was found in the parieto-occipital (P1, P3, P2, P4, POZ, PO3, PO5, PO7, PO4, PO6, PO8, O1, OZ) and fronto-central regions (F4, FC1, FC2 , FCZ, CZ, C1, CZ) in sensor space. Similarly, in source space, this change was observed across several tempro-parieto-occipital regions [e.g. cuneous, precuneus, posterior-dorsal part of the cingulate gyrus (dPCC), parieto-occipital sulcus, occipital pole, etc] and fronto-central regions (e.g. opercular part of the inferior frontal gyrus, central sulcus, pre-and post-central gyrus, etc.) (Fig. 5A) . No significant changes were observed in either ECT or MST non-responders (Fig. 1B and D) .
Finally, comparing ECT with MST intervention group, we identified that MSE in fine timescales (e.g. 510) was significantly lower post-treatment in ECT compared to the MST group, and increases in coarse timescales (e.g. 428) were significantly higher in ECT compared to the MST intervention group (Fig. 2A) . This effect was spatially global. Comparing antidepressant responders with non-responders (Fig. 2B ) identified significant differences between groups; however, this finding did not survive the clusterbased correction for multiple comparisons. The comparison revealed that responders may have a larger reduction in MSE post-treatment at finer time scales in brain regions such as the precuneus, bilateral cuneus, bilateral parietooccipital sulcus, bilateral occipital pole, bilateral lateral occi-temporal gyrus, calcarine sulcus, and bilateral posterior transverse collateral sulcus. Responders also appeared to have increased MSE post-treatment in coarser timescales (e.g. 440) mainly in the left inferior, middle and superior frontal sulcus, middle and superior frontal gyrus, and orbital part of inferior frontal gyrus. This latter observation is likely related to the higher number of ECT responders (compared to MST responders) who exhibited significant increases in complexity of coarse timescales (Fig. 1A) .
The impact of change in temporal complexity on mood and cognition
We then determined whether change in complexity was linked with the impact of seizure on mood and cognition. We found a negative association between per cent changes in MSE (%ÁMSE) and per cent change in HAMD (%ÁHAMD). This effect was selective to fine timescales in parieto-occipital and fronto-central regions (Fig. 3A) . Specifically, a negative association (P 5 0.01) was identified in tempro-parieto-occipital (TP7, P7, P5, P8, PO7, PO5, PO6, PO8, O1, O2, Oz) and fronto-central regions (AF4,  F1, FZ, F2, F4, FC1, FC2, FC4 , FCZ, C1, C4, CZ) in timescales 530. Source space analysis localized this effect to several regions including the dPCC, cuneus, precuneus, parieto-occipital sulcus, occipital pole, temporal sulci, and lateral occi-temporal sulcus, as depicted in Fig. 5C . This association illustrated that a spatially-specific decrease in complexity of fine timescales was linked with a greater improvement in depressive symptoms.
Moreover, we found a negative association between %ÁMSE and per cent change in general cognition (%ÁMoCA). This effect was spatially global in coarse timescales (e.g. 466) and included a wide range of timescales in parieto-central regions (e.g. PZ, POZ, P1, P2) (Fig.  3B) . Source-space analysis (Fig. 5D ) confirmed that this effect was spatially global across coarse timescales and included brain regions such as intraparietal sulcus and transverse parietal sulci. This negative association was replicated for change in autobiographical memory (%ÁAMI) (Supplementary Fig. 6A ) and was prominent in bilateral fronto-parietal brain regions. Likewise, source space analysis revealed a spatially global effect in coarse timescales with many brain areas involved including the bilateral superior parietal sulcus, and superior temporal sulcus ( Supplementary Fig. 7A ). Collectively, this negative association illustrated that an increase in MSE, in particular globally in coarser timescales, was linked with a greater decline in cognition.
These findings were region and timescale specific. That is, change in complexity in occipital regions and fine timescales was only associated with change in HAMD (e.g. O2 electrode, Timescale 4, r = À0.52, P = 0.0017), and not change in MoCA (Fig. 3C) , and change in complexity in parieto-central regions at coarser timescale (e.g. PZ electrode, Timescale 70, r = À0.63, P = 0.0038) was only associated with change in cognition, and not HAMD (Fig. 3D) .
Classifying antidepressant and cognitive response to seizure therapy
Finally, we examined whether change in temporal complexity could classify patients based on cognitive and antidepressant response to seizure therapy. We found that %ÁMSE classified the antidepressant response to seizure therapy with good performance and cognitive response with excellent performance as illustrated with the AUC property of the receiver operating characteristic (ROC) curve (Fig. 4) . Specifically, change in complexity of low timescales (e.g. 4-6,8) in right parieto-occipital brain regions (OZ, O2, PO8) offered good (AUC 5 0.8) prediction performance of antidepressant response [e.g. AUC (OZ electrode, Timescale 5) = 0.83, P 5 0.0001; Fig. 4A and B] and a fair (0.7 5 AUC 5 0.8) prediction performance was (1 to 60) and all timescales (1 to 70) (blue: decreases; red: increases following treatment) for responders and non-responders to ECT (A and B) and MST (C and D). Bottom: Each topography reflects the significant t-maps following correction for multiple comparison, using cluster-based nonparametric permutation test, depicting only the significant clusters P 5 0.05 and setting to 0 non-significant pixels. Topographies highlight the spatial characteristics of the reduction of MSE in fine timescales common to both ECT and MST responders (A and C) and the increase in MSE in coarse timescales following ECT alone (A). In ECT responders, there was a significant (cluster P = 0.003) global decrease in timescales 530 and a significant (cluster P = 0.002) global increase in coarser timescales. By contrast, in MST responders, only a wide spread reduction in timescales 520 was observed (cluster P = 0.033). In MST responders, the reduction of MSE in fine timescales (e.g. scale factor 4) was localized to parietooccipital (P1, P3, P2, P4, POZ, PO3, PO5, PO7, PO4, PO6, PO8, O1, OZ) and fronto-central regions (F4, FC1, FC2 , FCZ, CZ, C1, CZ). No significant changes were observed in either ECT or MST non-responders.
observed across low timescales (e.g. 1-22) in bilateral fronto-central (e.g. FC1, FC2, FCZ, F1) and bilateral parieto-occipital (e.g. O1, PO3, PO5, PO7, PO4, PO6, P7, P8) brain regions. In source space, similar prediction accuracy was identified for the right occipital pole at similar timescale [AUC (right occipital pole, Timescale 5) = 0.79, P 5 0.0001; Fig. 6A and B] . Moreover, change in complexity of Timescales 14 and higher in parieto-central (e.g. PZ) and then globally in coarser timescales provided excellent (e.g. AUC 5 0.9) prediction performance for change in cognition [e.g. AUC (P2 electrode, Timescale 23) = 0.98, P 5 0.0001; Fig. 4C and D] . In source space, similar prediction accuracy was identified for the intraparietal sulcus and transverse parietal sulci at similar timescale [AUC (intraparietal sulcus transverse parietal sulci, Timescale 22) = 0.97, P 5 0.00001; Fig. 6C and D] .
These findings were region-and timescale-specific. That is, change in complexity in occipital regions and fine timescales (e.g. OZ, Timescale 5; Moreover, the seizure therapy induced changes in autobiographical memory (%ÁAMI) could also be accurately (e.g. AUC range: 0.9-1.00; Supplementary Fig. 6B ) classified by change in complexity in coarse timescales (e.g. 447) in fronto-parietal regions ( Supplementary Fig.  6B ). Likewise, source space analysis revealed a spatially global effect in coarse timescales with many in frontal parietal brain regions (Supplementary Fig. 7B ). Finally, our results showed that change in complexity had better accuracy than neural oscillations in predicting antidepressant or cognitive response to seizure therapy (Supplementary Figs  2B and 3B) . Image shows the post hoc independent sample t-test statistics following cluster-based permutation test correction for multiple comparison, depicting only the significant clusters P 5 0.05, labelling only the significant corresponding regions of interest, and setting to 0 non-significant pixels. Image shows the t-test statistics comparing the change in MSE (post-pre/pre) between participants who received ECT and MST interventions (red = higher increases in ECT; blue = higher decreases in ECT). This image depicts that MSE in fine timescales (e.g. 510) was significantly lower post-treatment in ECT compared to the MST group, and increases in coarse timescales (e.g. 428) were significantly higher in ECT compared to MST intervention group. (B) Image shows the independent sample t-test statistics comparing the change in MSE (post-pre/pre) between participants who were considered responders to seizure therapy (550% reduction in HAMD from baseline) and non-responders (red = higher increases in responders; blue = higher decreases in responders). The regions of significance did not survive the cluster-based correction for multiple comparisons at cluster P 5 0.05, thereby, this image depicts the outcome of bootstrapping statistics only. Responders may have more reduction in MSE posttreatment in fine timescales in brain regions such as precuneus, bilateral cuneus, bilateral parieto-occipital sulcus, bilateral occipital pole, bilateral lateral occi-temporal gyrus, calcarine sulcus, and bilateral posterior transverse collateral sulcus. Responders may also have more increases posttreatment in coarser timescales (e.g. 440) mainly in the left inferior, middle and superior frontal sulcus, middle and superior frontal gyrus, and orbital part of inferior frontal gyrus.
Discussion
This study presented a novel biological target-i.e. complexity of the brain resting state dynamics-whose modulation in specific brain regions explained the antidepressant efficacy and cognitive consequences of seizure therapy in depression. In contrast to neural oscillations, significant changes in the complexity of brain dynamics were only present in responders of seizure therapy. Specifically, complexity of fine timescales was significantly reduced following successful ECT and MST. Across groups, the greater reduction in complexity of fine timescales in fronto-central and parieto-occipital regions (e.g. right occipital pole) was associated with greater improvement of depressive symptoms. In ECT, the complexity of coarse timescales was also significantly increased. Across groups, the greater global increase in complexity of coarse timescales was linked with the greater decline in general cognition. Finally, region and timescale-dependent changes in complexity classified patients based on antidepressant efficacy (e.g. in right occipital pole, Timescale 5) and cognitive consequences (e.g. intraparietal sulcus and transverse parietal sulci, Timescale 422), of seizure therapy with good (580%) and excellent (590%) accuracy, respectively.
ECT remains the most effective treatment in depression. Several hypotheses have attempted to explain the mechanism of action of ECT (reviewed in Farzan et al., 2014) . We recently proposed a unifying connectivity-resetting hypothesis, stating that ECT resets aberrant neural connectivity by activating the brain's major oscillatory pacemaker, thalamus and subsequently multiple thalamic loops (Farzan et al., 2014) . The significant impact of seizure therapy on neural oscillations has been quantified since early studies of ECT (reviewed in Farzan et al., 2014) . The most replicated finding is the general slowing of oscillations in ECT (Small et al., 1978) linked with improvement in mood (Fink and Kahn, 1957; Sackeim et al., 1996) . While we replicated previous findings demonstrating that ECT induces increase in power of slow oscillations, this effect was present in both ECT responders and non-responders. Moreover, we found no correlation between change in slow oscillations and improvement in symptoms. Most previous studies focused on limited and predefined frequency bands, using a few electrodes placed near the site of stimulation, or utilized statistical approaches that limited multidimensional analysis. The present study used non-parametric statistical approaches and two distinct modalities of seizure induction to comprehensively assess changes common to seizure therapy without a priori hypothesis or limiting analysis to regions and frequencies of interest. Our comprehensive Figure 4 Region-specific change in temporal complexity predicts change in mood and cognition. (A and C) Topographies depict area under the curve (AUC) of the receiver operating characteristic (ROC) curve of change in MSE in predicting antidepressant (A), and cognitive change (C) in response to seizure therapy at every electrode and timescale. The hot colours illustrate higher AUC and better prediction. Change in complexity of low timescales (e.g. 4-6, 8) in right parieto-occipital brain regions (OZ, O2, PO8) offered good (AUC 5 0.8) prediction performance of antidepressant response and a fair (0.7 5 AUC 5 0.8) prediction performance was observed across low timescales (e.g. 1-22) in bilateral fronto-central (e.g. FC1, FC2, FCZ, F1) and bilateral parieto-occipital (e.g. O1, PO3, PO5, PO7, PO4, PO6, P7, P8) brain regions (A). Change in complexity of timescales 14 and higher in parieto-central (e.g. PZ) and then globally in coarser timescales provided excellent (e.g. AUC 5 0.9) prediction performance for change in cognition. (B and D) The figures depict the ROC curve across all possible threshold values of the predictor for an electrode and timescale with best prediction performance for antidepressant response (OZ, Timescale 5) (B) and change in cognition [e.g. AUC (P2 electrode, Timescale 23) = 0.98, P 5 0.0001] (D). In both plots, x-axes represent false positive rates (1-specificity), y-axes the true positive values (sensitivity). The red circle shows the optimum operating point of the ROC curve. (B) At optimum point, this electrode and scale has 82% sensitivity and 77% specificity (good classification). (D) At optimum point, this electrode and scale has 89% sensitivity and 100% specificity (excellent classification). CI = confidence interval. In MST responders, a widespread reduction in timescales 520 was observed (cluster P 5 0.05). (B) By contrast, in ECT responders, there was significant (cluster P 5 0.01) global decrease in timescales 530 and significant (cluster P 5 0.01) global increase in coarser timescales. In MST responders, the reduction of MSE in fine timescales was found in several tempro-parieto-occipital [e.g. cuneous, precuneus, posterior-dorsal part of the cingulate gyrus (dPCC), parieto-occipital sulcus, occipital pole, etc.] and fronto-central brain regions (e.g. opercular part of the inferior frontal gyrus, central sulcus, pre-and post-central gyrus, etc) . No significant changes were observed in either ECT or MST non-responders. (C) Images illustrate the significant (P 5 0.05) Spearman correlation coefficients (rho) between per cent change in HAMD and MSE in 34 patients receiving seizure therapy. There were significant negative clusters (P 5 0.01) in timescale 520 factors in tempro-parieto-occipital regions including the bilateral dPCC, bilateral vPCC, bilateral cuneus, precuneus, parieto-occipital sulcus, occipital pole, temporal sulci, bilateral inferior temporal sulcus, bilateral lateral occi-temporal sulcus, bilateral calcarine sulcus, bilateral anterior and posterior transverse collateral sulcus. (D) Image illustrates spearman correlation coefficients (rho) between per cent change in MoCA and MSE across timescales in 19 patients receiving seizure therapy. There were significant negative clusters (P 5 0.005) in several central, parieto-central, parieto-occipital, occi-temporal, and temporal brain regions (as labelled on the image) across primarily coarser (430) timescales.
analysis revealed that it is the reduction in relative power of frequencies 18 Hz and above, particularly higher than 35 Hz, rather than increase in slow oscillations, that is linked with response to seizure therapy across ECT and MST. The observation that successful MST modulated high frequencies without significantly impacting slow oscillations further confirms that successful seizure therapy may be achieved without impacting the slow oscillations that are linked with the adverse effects of ECT as reported previously Nobler and Sackeim, 2008) and replicated in our study.
The peri-ictal characteristic of seizure reflects a rapid modification of the brain dynamicity. It seems intuitive that modulation of the brain dynamics would be a mechanism by which seizure exerts its therapeutic action. Yet this has been only minimally investigated. In an ECT case study in three patients with depression, reduction in MSE in fine timescales was reported (Okazaki et al., 2013) . Our results are also in line with a previous study that showed an abnormal enhancement in complexity of frontal brain regions in depression, which was normalized by antidepressant medication (Mendez et al., 2012) . Complexity, as indexed by Lempel-Ziv Complexity, was increased as a function of age in healthy subjects, a relationship not found in depression. Furthermore, 6 months of treatment with the antidepressant mirtazapine normalized the excess complexity in depression specifically in younger adults (Mendez et al., 2012) . Such findings may suggest that both medications and seizure therapy act on reducing complexity in depression, while the higher efficacy of seizure therapy may be linked to direct stimulation of oscillatory pacemakers. We found that antidepressant efficacy of seizure therapy was linked with local changes in complexity. Our findings and these previous studies encourage design of non-seizure interventions that target the same biological targets as seizure therapy toward eliminating the risk and complications of seizure induction.
Complexity of time series in biological systems is suggested to reflect plasticity to an ever changing environment and adaptability to stressors (McIntosh et al., 2014) . When examined across brain regions and timescales, the complexity of brain dynamics can arise from transient increases and decreases in correlated activity across brain regions reflecting rate of information generation (McIntosh et al., 2014) . Induction of seizure could reset integration and synchronization of information across brain regions, through activation of thalamus and multiple thalamic loops and interconnected brain regions, significantly impacting rate of information generation across distributed brain networks. The association between reduction in complexity and improvement in symptoms is in line with imaging findings that have shown that depression is associated with states of hyperconnectivity between frontoparietal and default mode network . The clinically relevant reduction of complexity in fronto-central and parieto-occipital regions adds to the resting state functional connectivity findings in functional MRI literature.
A recent study using functional MRI data from the Human Connectome Project showed differential association between functional connectivity of resting state networks and complexity of functional MRI time signals in fine versus coarse timescales (McDonough and Nashiro, 2014) . The timescales in this functional MRI study are coarse in comparison to the present high resolution EEG study, hindering direct interpretation. Yet, it provides evidence that there may be a link between seizure-induced changes in complexity and aberrant neural connectivity in depression. We suggest that a change in dynamics of functional connectivity between distributed brain regions may be a mechanism by which seizure therapy exerts its impact on behaviour. Design of non-invasive interventions that can selectively modify the complexity of the brain dynamics will enable careful examination of the consequence of region and network-specific modification of MSE on human behaviour.
Moreover, the finding that seizure induced changes in the occipital lobe (e.g. occipital pole) were linked to mood improvement and predicted therapeutic response is also in line with several lines of emerging evidence that have linked depression with impairment in this brain region (reviewed in Koch and Schultz, 2014) . For example, as reviewed by Koch and Schultz (2014) , a recent meta-analysis (Liao et al., 2013) reported the right occipital lobe, with the inferior fronto-occipital fibre tract, to be among the most consistently reported sites of decreased white matter integrity in this population. Furthermore, in addition to the changes in white matter structure, changes in resting state connectivity and grey matter volume have been previously shown in this brain region in depression (Grieve et al., 2013; Meng et al., 2014) . Moreover, a recent study has reported that occipital bending is more common in depression (Maller et al., 2015) . Finally, a prior study in poststroke depression has identified that post-stroke depression was closely linked with the right hemisphere lesion volume and its proximity to the occipital pole (Shimoda and Robinson, 1999) . Therefore, our finding that seizure therapy may exert its antidepressant efficacy by impacting the dynamics of the occipital region, particularly source localized to the occipital pole, not only complements these prior findings, but also provides a direction for development of novel antidepressant treatments.
This study also adds new insight about the link between region and timescale-dependent changes of complexity and human behaviour. We illustrated a region-specific reduction of MSE in fine timescales that was linked with improvement in mood, and a more spatially distributed (e.g. bilateral fronto-parietal) increase of MSE in coarse timescales that was linked with cognitive decline. Previous studies have reported both global and region-specific modulation in complexity, such as during development (Misic et al., 2010) and ageing (McIntosh et al., 2014) , respectively. Indeed, the observed link between increase in MSE in coarse timescales and cognitive decline is consistent with findings in Alzheimer's disease . Our findings also extend previous studies that revealed significant modifications in this marker during adolescence (Vakorin et al., 2013) , when the prevalence rate of depression peaks, and in disorders of cognition and affect with overlapping symptoms with depression including autism spectrum disorder (Bosl et al., 2011) or schizophrenia , in which seizure therapy is also indicated.
MST treatment frequency may be an important dimension involved in production of a seizure. The majority of prior MST trials have applied MST at 100 Hz frequency to achieve seizure induction. However, it was proposed that the optimal frequency for seizure induction may be in the vicinity of 22 Hz (Peterchev et al., 2010) . In our sample, the most common MST frequency used was 100 Hz (in 12/15 subjects), while a few patients who also took part in the resting state EEG assessments received lower frequency of stimulation to induce seizure. Nevertheless, the present EEG study was not designed to evaluate the impact of different frequency of stimulation on therapeutic outcome. We propose that the markers presented in this study have the potential to be used to protect against any potential cognitive adverse effects through neurophysiological monitoring that may predate any cognitive deterioration.
Finally, our findings support a spatiotemporally-specific antidepressant target for seizure therapy. First, the association between change in MSE and depressive symptoms was identified in fronto-central and parieto-occipital electrodes and source localized to several parieto-occipital brain regions including the occipital pole. Second, the reduction in MSE was observed more localized to these brain regions in fine timescales in responders in MST, which is a more focal method of seizure induction. Consistently, the association between change in neural oscillations and depressive symptoms was also localized to fronto-central and parieto-occipital brain regions and high frequency oscillations that correspond to fine timescales. Fourth, the classification performance of the change in complexity was region and timescale-specific. Brain regions at which change in complexity classified antidepressant response with good accuracy failed to classify cognitive response, and brain regions at which change in complexity classified cognitive response failed to classify antidepressant response. Recent evidence indicates the possibility of modulating the temporal complexity of brain signals by network guided repetitive TMS (Farzan et al., 2016) . Therefore, treatment of depression may benefit from design of more targeted seizure induction strategies or non-seizure treatments (e.g. repetitive TMS) that could modulate complexity with spatiotemporal specificity.
